A team led by Professor Hui Wei, a pioneer in nanozyme research at Nanjing University, has unveiled an ultrasmall theranostic nanozyme with the potential to transform the diagnosis and treatment of abdominal aortic aneurysm (AAA)—a highly lethal vascular disease with limited therapeutic options.

Tiny immune cells called microglia protect the central nervous system (CNS) in a multitude of ways: They provide innate immunity, shape neurodevelopment, maintain homeostasis and modulate neurological disorders. That functionality can be lost, however, when microglia acquire mutations.

When someone walks into an emergency room with symptoms of a stroke, every second matters.

A new study has identified a critical “pressure sensor” inside the kidney that helps the body control blood pressure and fluid levels.

Pneumonia is a disease that burdens the health care system with more than 1.2 million emergency room visits each year and more than 41,000 adult deaths in the United States. Worldwide, more than one million children under the age of five die of the disease annually.

Dr. Vadim Jucaud’s lab at the Terasaki Institute has introduced a new organ-on-a-chip platform that recapitulates age-dependent immune responses, offering a more accurate testing bed for evaluating cancer vaccine performance in older adults, the population most affected by cancer and often overlooked in traditional preclinical testing.